Description:

E2805 Adverse Event Form - (CTCAE v3) NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0538F350-3C05-47A5-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0538F350-3C05-47A5-E044-0003BA3F9857

Keywords:
Versions (5) ▾
  1. 9/19/12
  2. 1/8/15
  3. 1/9/15
  4. 1/9/15
  5. 7/8/15
Uploaded on:

July 8, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

E2805 Adverse Event Form - (CTCAE v3) NCT00326898

INSTRUCTIONS: Complete this form at the end of each cycle (1 cycle = 3 weeks), and at required follow-ups if specified by the Long-Term Follow-Up Form (to report late adverse events).

Header
Patient demographics
Data amendment
On Treatment
On Treatment Report Period (Choose one)
Off Treatment
Off Treatment Report Period (since registration)
Adverse Event Current Assessment
Were adverse events assessed during this report period (cycle)
Blood/bone Marrow/metabolic - Labs
CTC Adverse Event Term
CTC AE Attribution Code
Action Taken at Time of Adverse Event
Outcome of Adverse Event
NON-HEMATOLOGIC
CTC Adverse Event Term
CTC AE Attribution Code
Action Taken at Time of Adverse Event
Outcome of Adverse Event
Ii. Infections
CommonToxicity --CTC Adverse Event Short Name (Specify site for each event)
CTC AE Attribution Code
Action Taken at Time of Adverse Event
Outcome of Adverse Event
Other Adverse Events
CTC AE Attribution Code
Action Taken at Time of Adverse Event
Outcome of Adverse Event
Comments

Similar models